Menu Back toSS01: Utilization of Registry Data for Regulatory Application - Implementation as External Control Arm, Post-Marketing Efficacy Assessment -

18th DIA Japan Annual Meeting 2021

All prices are exclusive of 10% Japanese consumption tax

SS01: Utilization of Registry Data for Regulatory Application - Implementation as External Control Arm, Post-Marketing Efficacy Assessment -

Session Chair(s)

Hideki  Oi

Hideki Oi

  • Director, Department of Clinical Data Science, Clinical Research & Education Pro
  • National Center of Neurology and Psychiatry (NCNP), Japan
Hideharu  Yamamoto, PhD

Hideharu Yamamoto, PhD

  • Biostatistics Deputy Dept Manage, Biometrics Dept
  • Chugai Pharmaceutical Co., Ltd., Japan

Speaker(s)

Yuki  Ando, PhD

Yuki Ando, PhD

  • Senior Scientist for Biostatistics
  • Pharmaceuticals and Medical Devices Agency, Japan
Taro  Shibata, MSc

Taro Shibata, MSc

  • Chief, Biostatistics Division
  • Center for Research Administration and Support, National Cancer Center, Japan
Hideki  Oi

Hideki Oi

  • Director, Department of Clinical Data Science, Clinical Research & Education Pro
  • National Center of Neurology and Psychiatry (NCNP), Japan
Yoshiaki  Nakamura, MD, PhD

Yoshiaki Nakamura, MD, PhD

  • Translational Research Support Section/Department of Gastrointestinal Oncology
  • National Cancer Center Hospital East, Japan
Nobushige  Matsuoka, PhD

Nobushige Matsuoka, PhD

  • Manage, Biometrics & Data Management
  • Pfizer R&D Japan G.K., Japan

Contact us